Practical management of coagulopathy associated with warfarin.
Garcia
David
D
Department of Internal Medicine, University of New Mexico, MSC08 4630, Albuquerque, NM 87131, USA. davgarcia@salud.unm.edu
Crowther
Mark A
MA
Ageno
Walter
W
D000284:Administration, Oral; D000925:Anticoagulants / Q000009:adverse effects*; D000933:Antifibrinolytic Agents / Q000008:administration & dosage; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D019934:International Normalized Ratio; D012307:Risk Factors; D014812:Vitamin K / Q000008:administration & dosage; D014859:Warfarin / Q000009:adverse effects*
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D014812:Vitamin K; D014859:Warfarin